Vanda pharmaceuticals inc. (VNDA)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Net product sales

237,475

227,188

219,299

208,949

197,239

193,118

184,353

176,554

171,260

165,083

159,051

156,197

150,170

146,017

139,622

129,484

121,037

109,925

83,405

56,620

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,502

6,950

7,217

7,319

7,090

6,227

5,806

5,865

5,938

6,388

6,069

5,121

4,481

3,356

2,210

0

0

0

Licensing agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,746

29,732

28,721

27,635

26,789

26,789

26,789

26,789

26,789

26,789

26,789

26,789

26,789

26,790

26,715

0

0

0

Total revenues

237,475

227,188

219,299

208,949

197,239

193,118

184,353

176,554

171,260

165,083

159,051

156,197

150,170

146,017

139,622

129,484

121,037

109,925

93,446

79,884

63,164

50,157

43,570

37,497

34,954

33,879

33,016

32,595

32,654

32,727

33,177

32,858

31,910

31,270

30,146

30,467

0

0

0

Operating expenses:
Cost of goods sold excluding amortization

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold excluding amortization

-

-

23,930

22,216

-

20,508

19,632

19,089

18,405

17,848

18,329

20,794

22,759

24,712

25,611

25,131

24,403

23,462

17,994

11,682

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Research and development

50,898

48,649

48,497

48,540

47,456

43,594

40,826

39,614

37,396

38,547

36,007

33,123

32,175

29,156

30,289

32,969

32,215

29,145

25,150

18,877

16,445

19,230

20,747

25,068

27,654

28,502

33,168

35,305

41,695

45,764

45,385

43,400

36,909

28,996

22,512

16,741

0

0

0

Selling, general and administrative

135,728

129,736

117,640

113,466

109,958

105,751

111,878

116,955

120,366

123,841

116,699

107,483

100,794

99,787

104,761

101,311

95,015

84,531

72,972

65,804

75,557

84,644

77,250

71,701

48,822

25,082

19,014

16,420

14,761

14,517

14,002

13,566

12,537

11,486

10,195

10,326

0

0

0

Intangible asset amortization

1,525

1,505

1,512

1,509

1,507

1,527

1,627

1,662

1,696

1,750

3,423

5,934

8,444

10,933

11,771

11,771

11,771

12,972

10,565

8,158

5,833

2,254

2,095

1,936

1,691

1,495

1,495

1,495

1,495

1,495

1,495

1,495

1,495

1,495

1,495

1,490

0

0

0

Total operating expenses

212,703

204,378

191,582

185,758

180,030

171,380

173,915

177,272

177,815

181,986

174,458

167,334

164,172

164,588

172,432

171,182

163,404

150,110

49,044

27,389

26,817

30,095

100,993

98,903

78,167

55,079

53,806

53,349

58,080

61,905

60,882

58,461

50,941

41,977

34,202

30,073

0

0

0

Loss from operations

24,772

22,810

27,717

23,191

17,209

21,738

10,438

-718

-6,555

-16,903

-15,407

-11,137

-14,002

-18,571

-32,810

-41,698

-42,367

-40,185

44,402

52,495

36,347

20,062

-57,423

-61,406

-43,213

-21,200

-20,790

-20,754

-25,426

-29,178

-27,705

-25,603

-19,031

-10,707

-4,056

394

0

0

0

Other income

6,099

6,218

5,819

5,332

4,471

3,608

2,839

2,205

1,814

1,472

1,227

1,054

828

665

607

464

365

320

250

192

151

124

142

145

144

145

160

204

252

561

601

638

681

461

518

498

0

0

0

Income (loss) before income taxes

30,871

29,028

33,536

28,523

21,680

25,346

13,277

1,487

-4,741

-15,431

-14,180

-10,083

-13,174

-17,906

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-27,104

-24,965

-18,350

-10,246

-3,538

892

0

0

0

Income Tax Expense (Benefit)

-85,735

-86,525

-88,122

78

150

138

275

198

115

136

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-286

-399

-450

-444

-2,443

-2,367

0

0

0

Net Income (Loss) Attributable to Parent

116,651

115,553

121,697

28,445

21,530

25,208

13,010

1,289

-4,856

-15,567

-14,333

-10,213

-13,297

-18,010

-32,203

-41,234

-42,002

-39,865

44,652

52,687

36,498

20,186

-57,281

-61,261

-43,069

-21,055

-20,630

-20,550

-25,174

-28,617

-26,818

-24,566

-17,900

-9,802

-1,095

3,259

0

0

0

Earnings Per Share [Abstract]
Basic (in dollars per share)

0.01

0.08

1.88

0.22

-0.01

0.20

0.14

0.09

0.07

-0.05

-0.10

-0.03

-0.17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.26

-0.19

-0.28

-0.28

-0.19

-0.11

-0.05

0.00

0.11

0.05

Diluted (in dollars per share)

0.01

0.07

1.84

0.21

-0.01

0.20

0.13

0.09

0.06

-0.05

-0.10

-0.03

-0.17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.26

-0.19

-0.28

-0.28

-0.19

-0.11

-0.05

0.00

0.11

0.04

Basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.11

-0.29

-

-0.22

-0.13

-0.24

-

-0.04

-0.64

-0.79

-

-0.17

-0.12

-0.16

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding:
Basic (in shares)

53,806

53,398

53,297

53,101

52,752

52,541

52,389

52,172

46,336

44,938

44,885

44,718

44,398

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,233

28,226

28,226

28,226

28,115

28,107

28,103

28,101

28,003

27,896

Diluted (in shares)

54,870

57,513

54,541

54,579

52,752

55,300

54,709

53,945

48,225

44,938

44,885

44,718

44,398

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,233

28,226

28,226

28,226

27,279

28,107

28,103

28,936

28,466

28,438

Weighted average shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,515

43,202

43,104

-

42,435

41,991

41,744

-

33,886

33,874

33,678

-

31,332

28,377

28,345

-

-

-

-

-

-

-

-

-

-